Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | 114,200 | reported | 26 May 2026 | tx 1+114,200 |
| Black Diamond Therapeutics, Inc. | 30,550 | reported | 12 Jun 2025 | tx 6+131,065 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 May 2026 | GRANT_AWARD | Zentalis Pharmaceuticals, Inc. | 114,200 | 0.00 USD | |
| 12 Jun 2025 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 30,550 | 0.00 USD | deriv |
| 13 Dec 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 4,500 | 2.50 USD | |
| 20 Sept 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 2,354 | 4.78 USD | |
| 21 Jun 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 2,011 | 4.98 USD | |
| 06 Jun 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 30,550 | 0.00 USD | deriv |
| 10 Apr 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 61,100 | 0.00 USD | deriv |